Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity

MLA

Alberto Moreno, et al. “Divergence of Variant Antibodies Following SARS-CoV-2 Booster Vaccines in Myeloma and Impact of Hybrid Immunity.” Npj Vaccines, vol. 9, no. 1, Oct. 2024, pp. 1–5. EBSCOhost, https://doi.org/10.1038/s41541-024-00999-6.

APA

Alberto Moreno, Kelly Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo, Jeffrey M. Switchenko, Bushra Wali, Jonathan L. Kaufman, Craig C. Hofmeister, Nisha S. Joseph, Sagar Lonial, Kavita M. Dhodapkar, Madhav V. Dhodapkar, & Mehul S. Suthar. (2024). Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity. Npj Vaccines, 9(1), 1–5. https://doi.org/10.1038/s41541-024-00999-6

Chicago

Alberto Moreno, Kelly Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo, Jeffrey M. Switchenko, et al. 2024. “Divergence of Variant Antibodies Following SARS-CoV-2 Booster Vaccines in Myeloma and Impact of Hybrid Immunity.” Npj Vaccines 9 (1): 1–5. doi:10.1038/s41541-024-00999-6.